Status: Recruiting
Dengvaxia US Pregnancy Registry
The primary objective of this study is to assess maternal, obstetrical, pregnancy, and neonatal and infant outcomes among women and their offspring(s) vaccinated with Dengvaxia during their pregnancy
Participants needed: 500
Trial details
Biological sex: AllType: ObservationalSponsor: Sanofi Pasteur, a Sanofi CompanyUpdated: Jan 21, 2026Locations: 1Duration: 22 Months
Eligibility criteria
Sufficient evidence to confirm the case qualifies as "exposed during pregnancy"; [+1]